School of Medicine


Showing 51-76 of 76 Results

  • Lynn Million

    Lynn Million

    Clinical Professor, Radiation Oncology - Radiation Therapy

    BioLynn Million specializes in the treatment of cancer. She has practiced Radiation Oncology for more than 30 years. Dr. Million has a special interest in the treatment of sarcoma’s of soft tissue, bone and cartilage in children, young adolescents and adults.

  • Everett J. Moding, MD, PhD

    Everett J. Moding, MD, PhD

    Assistant Professor of Radiation Oncology (Radiation Therapy)

    Current Research and Scholarly InterestsMy laboratory performs translational research using analysis of human samples to identify critical mediators of treatment resistance that can be validated in preclinical models and targeted to enhance the efficacy of cancer therapy.

  • Prithvi Mruthyunjaya, MD, MHS

    Prithvi Mruthyunjaya, MD, MHS

    Professor of Ophthalmology and, by courtesy, of Radiation Oncology

    Current Research and Scholarly InterestsDr Mruthyunjaya has maintained a broad research interest with publications in both ocular oncology and retinal diseases.
    His focus is on multi-modal imaging of ocular tumors and understanding imaging clues that may predict vision loss after ocular radiation therapy. He coordinates multi-center research on the role of genetic testing and outcomes of treatments of ocular melanoma.
    In the field of retinal diseases, his interests are in intra-operative imaging to enhance surgical accuracy.

  • Jinghong Penny Peng

    Jinghong Penny Peng

    Clinical Instructor, Radiation Oncology - Radiation Physics

    Current Research and Scholarly Interests1. IMRT Treatment planning
    2. IGRT Radiation Therapy
    3. Real time prostate implant
    4. 4D CT and Respiratory Gating Radiation Therapy
    5. HDR for breast cancer and GYN cancer
    6. Xoft Electronic Brachytherapy

  • Guillem Pratx

    Guillem Pratx

    Associate Professor of Radiation Oncology (Radiation Physics)

    Current Research and Scholarly InterestsThe Physical Oncology Lab is interested in making a lasting impact on translational cancer research by building novel physical tools and methods.

  • Yushen Qian, MD

    Yushen Qian, MD

    Clinical Assistant Professor, Radiation Oncology - Radiation Therapy

    BioDr. Qian is a board-certified radiation oncologist and a clinical assistant professor in the Stanford University School of Medicine, Department of Radiation Oncology.

    In his clinical practice, he specializes in urologic, head and neck, and thoracic cancers, but treats a broad spectrum of cancers including lymphoma, gastrointestinal, and brain tumors. For each patient, he develops a comprehensive, compassionate care plan customized to individual needs. His goal is to deliver the most effective cancer treatment to help patients enjoy the best possible health and quality of life.

    In addition to his clinical practice, Dr. Qian has conducted extensive research that is often focused on the impact of radiation therapy on patient outcomes and health care system costs.

    He has presented the findings at annual meetings of the American Radium Society, American Society for Radiation Oncology, American Society of Clinical Oncology Cancer Survivorship Symposium, Palliative Care in Oncology Symposium, and elsewhere.

    Dr. Qian has published articles in journals such as Clinical Cancer Research, the Journal of Clinical Oncology, Practical Radiation Oncology, the International Journal of Radiation Oncology • Biology • Physics (IJROBP), and more.

    Dr. Qian co-authored the chapter on radiation therapy for liver tumors in the book Radiation Therapy for Hepatocellular Carcinoma: Clinical Data. He also co-authored the chapter on liver care for the book Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy.

    He has earned numerous honors, including the Malcolm A. Bagshaw Award for leadership and outstanding scientific achievement.

  • Elham Rahimy, MD

    Elham Rahimy, MD

    Clinical Assistant Professor, Radiation Oncology - Radiation Therapy

    BioDr. Rahimy is a radiation oncologist who treats patients with brain, spine, and gastrointestinal tumors. She received her medical training at Yale, followed by a residency in radiation oncology at Stanford. She is a clinical assistant professor with the Stanford School of Medicine Department of Radiation Oncology.

    Dr. Rahimy specializes in treating several types of cancer, including brain tumors, such as glioma and glioblastoma, spine tumors, metastatic disease, and gastrointestinal cancer, such as rectal cancer and pancreatic cancer. She is credentialed for CyberKnife Radiosurgery. She is also actively involved in radiation oncology research and clinical trials. Her interests include improving patient and resident education and enhancing patient quality of life and survivorship. Dr. Rahimy’s research has been published in a variety of journals. She is also the current radiation oncology medical student clerkship director.

  • Mohammad Shahrokh Esfahani

    Mohammad Shahrokh Esfahani

    Assistant Professor of Radiation Oncology (Radiation and Cancer Biology)

    BioWith a primary focus on high-dimensional data, I have significant expertise in developing machine learning tools. Much of my work involves constructing Bayesian models, which effectively convert 'prior knowledge', either inherent in the dataset or obtained from external sources, into mathematical terms—more specifically, prior probabilities.

    My recent research efforts have centered on the analysis of genetic and epigenetic signals within cell-free DNA assays. This interest in epigenetics led to the development of a pioneering technique known as EPIC-seq, which has broadened our understanding of this complex field.

    It's notable that traditional computational methods in cancer genomics often fall short when confronted with an exceedingly low signal-to-noise ratio—a common scenario in cfDNA analyses. As such, there's an emerging need to devise innovative, robust methods capable of overcoming this limitation—a research area that I'm deeply committed to and actively engaged in.

  • Lawrie Skinner

    Lawrie Skinner

    Clinical Assistant Professor, Radiation Oncology - Radiation Physics

    BioDr Skinner is a Board certified therapeutic medical physicist with interests in novel 3D printed devices and a research background in synchrotron x-ray scattering, neutron scattering, molecular dynamics and Monte Carlo computational modelling.

  • Kendric C. Smith

    Kendric C. Smith

    Professor of Radiation Oncology, Emeritus

    Current Research and Scholarly InterestsThe photochemistry and radiation chemistry of DNA, the genetic control and biochemical bases of the multiple pathways of DNA repair, and the roles of DNA repair processes in radiation and spontaneous mutagenesis. Over 190 papers have been published on these and related topics.

  • Scott G. Soltys, MD

    Scott G. Soltys, MD

    Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsMy clinical and research interests focus on the development of new radiation techniques involving stereotactic radiosurgery and radiotherapy for the treatment of malignant and benign tumors of the brain and spine, as well as functional disorders such as trigeminal neuralgia.

  • Gregory Arthur Szalkowski

    Gregory Arthur Szalkowski

    Clinical Assistant Professor, Radiation Oncology - Radiation Physics

    Current Research and Scholarly InterestsWorkflow automation, radiotherapy quality assurance, machine learning

  • Nicholas Trakul, MD, PhD

    Nicholas Trakul, MD, PhD

    Clinical Associate Professor, Radiation Oncology - Radiation Therapy

    BioDr. Nicholas Trakul is a radiation oncologist with Stanford Medicine Cancer Center and clinical associate professor of Radiation Oncology-Radiation Therapy with Stanford School of Medicine. Dr. Trakul serves as Medical Director for Stanford Medicine Radiation Oncology in Pleasanton and for the Stanford Medicine I Sutter Health Cancer Collaborative in Castro Valley.

    Dr. Trakul completed residency training at Stanford in 2013 and then joined the faculty at the University of Southern California, where he specialized in head and neck and central nervous system malignancies, with an emphasis on stereotactic radiosurgery (SRS) and stereotactic ablative radiotherapy (SABR/SBRT). He is widely published as first author in peer-reviewed journals. His research focus involves the creation of novel clinical databases as well as outcomes in the treatment of head and neck, gastrointestinal and thoracic malignancies. In 2017, Dr. Trakul returned to Stanford Medicine, becoming the Medical Director of Stanford Medicine Radiation Oncology in Pleasanton. In 2020, he was named Medical Director of Stanford Radiation Oncology Network Sites. In February 2022, Dr. Trakul assumed the medical directorship of Eden Radiation Oncology Center, the first site to become operation under the Stanford/Sutter Cancer Collaborative. He is focused on providing access to high quality radiation therapy, collaboration with community health care systems and creating/maintaining productive and high engagement workplace culture. He believes in providing personalized, high-quality care, and bringing new technology to the East Bay, allowing patients to access cancer care while staying connected to their communities and support networks.

  • Lucas Kas Vitzthum, MD

    Lucas Kas Vitzthum, MD

    Clinical Associate Professor, Radiation Oncology - Radiation Therapy

    BioDr. Vitzthum is a radiation oncologist and clinical associate professor of radiation oncology at Stanford University School of Medicine. He specializes in the treatment of gastrointestinal and thoracic cancers. He also has a clinical and research interest in oligometastatic cancer, which is cancer that has metastasized to a limited number of sites beyond its origin.

    He began his career in biomedical engineering and is passionate about integrating new technologies to advance patient care.

    Dr. Vitzthum delivers treatment personalized to each patient’s condition, overall health, and goals. He believes clear communication between doctor and patient is vital to help patients make informed care decisions.

    His research interests include clinical trial development, survivorship, and predictive modeling to personalize patient treatment. He is especially interested in pursuing research that can address unmet clinical needs.

    Dr. Vitzthum has received research support through the Radiological Society of North America, the American Society of Clinical Oncology’s Conquer Cancer Foundation, and the UCSD Altman Clinical and Translational Research Institute. His work has appeared in International Journal of Radiation Oncology Biology Physics, Annals of Oncology, JAMA Oncology, Clinical Cancer Research, and other publications.

    He is a member of the American College of Radiation Oncology, American Society for Radiation Oncology, American Society of Clinical Oncology, and Radiologic Society of North America.

    Dr. Vitzthum is also interested in improving access to high-quality cancer care for under-served populations domestically and abroad.

  • Lei Wang

    Lei Wang

    Clinical Professor, Radiation Oncology - Radiation Physics

    BioClinical research on Linac and Cyberknife based SRS and SBRT which includes: small field dosimety, machine and patient quality assurance, treatment planning, etc; new QA tool and methodology development; new treatment technology implementation to keeping high standard in patient care.

  • Lei Xing

    Lei Xing

    Jacob Haimson and Sarah S. Donaldson Professor and Professor, by courtesy, of Electrical Engineering

    Current Research and Scholarly Interestsartificial intelligence in medicine, medical imaging, Image-guided intervention, molecular imaging, biology guided radiation therapy (BGRT), treatment plan optimization

  • Jiangbin Ye

    Jiangbin Ye

    Assistant Professor of Radiation Oncology

    Current Research and Scholarly InterestsOne hallmark of cancer is that malignant cells modulate metabolic pathways to promote cancer progression. My professional interest is to investigate the causes and consequences of the abnormal metabolic phenotypes of cancer cells in response to microenvironmental stresses such as hypoxia and nutrient deprivation, with the prospect that therapeutic approaches might be developed to target these metabolic pathways to improve cancer treatment.

  • Sandra Zaky

    Sandra Zaky

    Clinical Associate Professor, Radiation Oncology - Radiation Therapy

    BioDr. Zaky is a board certified Radiation Oncologist. She received a Bachelor’s of Science in Biomedical/Electrical Engineering at Marquette University. She worked in research and development as an Engineer, and eventually received a Masters of Science in Immunology from Albany Medical College. Her research thesis focused on a novel therapy to treat hormone-receptor positive breast cancer. She continued to study breast cancer with her research during her Radiation Oncology residency; she integrated her research in the laboratory with her clinical research in triple-negative breast cancer. Since completing residency, she has worked as a general radiation oncologist, and her special interests include breast cancer, skin cancer, CNS tumors and stereotactic radiotherapy.